Target intelligence / Profile preview

Ticagrelor Active Metabolite (AR-C124910XX)

Target
AR-C124910XX
Molecular classification
Small molecule, Drug metabolite
01

Overview

The major active metabolite of ticagrelor, AR-C124910XX, is formed primarily by CYP3A4 and CYP3A5 in the liver. It is an equipotent reversible antagonist of the platelet P2Y12 receptor, contributing significantly to the antiplatelet effects of ticagrelor. Its formation and elimination can be influenced by other drugs and patient-specific factors, affecting overall therapeutic efficacy and safety.

Other names
AR-C124910XXTicagrelor metabolite
02

Mechanism of action

Reversible antagonist of the platelet P2Y12 receptor

03

Biological functions

Platelet aggregation inhibitionP2Y12 receptor antagonism
04

Disease associations

Cardiovascular diseaseThrombotic disorders
05

Safety considerations

Bleeding riskDrug interactions affecting CYP3A activity
06

Interacting drugs

Ticagrelor

3 more in the full profile.

Beyond the preview

Go deeper on Ticagrelor Active Metabolite (AR-C124910XX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ticagrelor Active Metabolite (AR-C124910XX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call